Literature DB >> 6441826

Failure of cephalosporins to cure experimental listeriosis.

B Kawaler, H Hof.   

Abstract

In vitro, 15 strains of various serotypes of Listeria monocytogenes were found to be susceptible to cefazedone and cephalotin. Other cephalosporins, such as cefotaxime, were much less active. In spite of their relatively good in vitro activities, however, neither cefazedone nor cephalotin reduced the bacterial counts in mice infected with a virulent strain of L. monocytogenes. In contrast, ampicillin was active both in vitro and in vivo. Cephalosporins should not be used clinically for treating listeriosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441826     DOI: 10.1016/s0163-4453(84)90486-9

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Listeria monocytogenes meningitis in previously healthy adults.

Authors:  C J Hearmon; S K Ghosh
Journal:  Postgrad Med J       Date:  1989-02       Impact factor: 2.401

Review 2.  Antibiotic susceptibilities of Listeria: in vitro studies.

Authors:  E P Espaze; A E Reynaud
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 3.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

Review 4.  Listeria monocytogenes peritonitis in a patient on peritoneal dialysis: a case report and review of the literature.

Authors:  Mufazzal Ahmad; Abirami Krishnan; Elizabeth Kelman; Vanessa Allen; Joanne M Bargman
Journal:  Int Urol Nephrol       Date:  2008-06-19       Impact factor: 2.370

5.  Susceptibilities of Listeria species isolated from food to nine antimicrobial agents.

Authors:  C M Franco Abuín; E J Quinto Fernández; C Fente Sampayo; J L Rodríguez Otero; L Domínguez Rodríguez; A Cepeda Sáez
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

6.  Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.

Authors:  A E Girard; D Girard; A R English; T D Gootz; C R Cimochowski; J A Faiella; S L Haskell; J A Retsema
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

7.  Population structure-guided profiling of antibiotic resistance patterns in clinical Listeria monocytogenes isolates from Germany identifies pbpB3 alleles associated with low levels of cephalosporin resistance.

Authors:  Martin A Fischer; Sabrina Wamp; Angelika Fruth; Franz Allerberger; Antje Flieger; Sven Halbedel
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.